Printer Friendly
The Free Library
14,611,208 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Company Review of Teva Pharmaceutical Industries Ltd Including Information on 75 Deals Made and 76 Partnering Companies from 2000 - 2005.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c26998 ) has announced the addition of Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in  Ltd Deals Briefing to their offering.

Description

Teva Pharmaceutical Industries Ltd Deals briefing provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 view of the 75 deals made by Teva Pharmaceutical Industries Ltd and its subsidiaries with 76 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January January: see month.  2000 and July July: see month.  2005.

Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

The report contains:

a brief company profile including subsidiary names

financial information where disclosed

a deals overview

specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 indexes including deals by partner company, subsidiary company, therapy focus and development stage

a detailed listing of the company's deals and alliances.

Key questions answered

Teva Pharmaceutical Industries Ltd Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

identifying active partners

tracking competitor activity

benchmarking
For the geolocating game, see benchmarking (geolocating). For other uses of the term 'benchmark' see benchmark.


Benchmarking (also "best practice benchmarking" or "process benchmarking") is a process used in management and particularly strategic
 deals

comparing the finances of different deal types.

Teva Pharmaceutical Industries Ltd Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Teva Pharmaceutical Industries Ltd.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma Pharma may be an abbreviation for:
  • Pharmaceutical company
  • Pharmaceutical drug
  • Pharmacology
  • Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Pharma (record label)
 revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.
Who should buy the report
This report is essential reading for board and executive management,
and individuals in:
business development
licensing/partnering
deal making
business strategy
marketing and promotion
distribution and manufacturing (including contract services).

Topics Covered
Introduction
About Partneringdesk Deals briefings
Chapter 1: Company profile
Chapter 2: Financial data and deals overview
Chapter 3: Summary of deals
Deals involving Teva Pharmaceutical Industries Ltd by partner company
Deals involving Teva Pharmaceutical Industries Ltd by subsidiary
Deals involving Teva Pharmaceutical Industries Ltd by therapy focus
Deals involving Teva Pharmaceutical Industries Ltd by development
stage
Chapter 4: List of deals
Glossary
List of Tables
Table 2.1 Teva Pharmaceutical Industries Ltd financial summary
Table 2.2 Teva Pharmaceutical Industries Ltd deals by deal type
Table 2.3 Teva Pharmaceutical Industries Ltd deals by therapy focus
Table 2.4 Teva Pharmaceutical Industries Ltd deals by development
stage
Table 2.5 Teva Pharmaceutical Industries Ltd deals by industry sector

Companies Mentioned
Asche AG
Berlex
Berlex Laboratories
CIS Bio International
Collateral Therapeutics
GTB GenTherapeutika (until 2003-05-01)
MAP Medical Technologies
Nihon Schering KK


For more information visit http://www.researchandmarkets.com/reports/c26998
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:7ISRA
Date:Nov 17, 2005
Words:544
Previous Article:UniPress Software Reaffirms Industry Best Practices Commitment Through Employee ITIL Certification; UniPress' Entire Professional Services Group...
Next Article:Network Outsourcing Market Grows and is Expected to Be Worth $70 Billion by 2011 as Companies Try to Improve Their IT Infrastructure While Reducing...
Topics:



Related Articles
Bentley Pharmaceuticals and Teva Pharmaceutical Industries Enter Into Strategic Alliance in Spain; Sign Agreements to License Generic and Branded...
TEVA SIGNS PACT TO BUY HONEYWELL PHARMACEUTICAL IN ITALY.
Teva to Webcast Ivax Acquisition Luncheon Presentation.
Teva Draws Down on Recently Established US$ 350 Million Syndicated Loan Facility.
Teva and IVAX Receive European Commission Approval for Acquisition.
Teva Announces Tentative Approval of Simvastatin Tablets; Provides Update on 180-Day Exclusivity.
FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR.
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two...
Teva Comments About the Acquisition of Merck KGaA Generic Business.
Teva Provides Update on Generic Lotrel(R) Litigation.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles